Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07754474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity

StatusRecruiting
PhasePhase 1
Started2026-09-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jan 17, 2027 → Jun 21, 2027
See other at-risk trials from Boehringer Ingelheim

Amendment history

2026-09-02
Study Status, Study Design v1
Recruitment opened
Enrollment increased: 35 → 70 participants
Primary completion pushed: 2027-01-17 → 2027-06-21
Completion pushed: 2027-01-17 → 2027-06-21
2026-08-05
Original filing
Boehringer Ingelheim
221 trials monitored
See 15 trials at risk
Obesity
3,523 trials monitored
See 133 trials at risk
The main objectives of this trial are to investigate safety, tolerability of alternative dose titration strategies and pharmacokinetics (PK) of BI 3034701 in participants with overweight / obesity and at least one weight related co-morbidity following subcutaneous administration.
Trial Details
NCT Number NCT07754474
Lead Sponsor Boehringer Ingelheim
Conditions Overweight, Obesity
Enrollment 70 participants
Start Date 2026-09-01
Primary Completion 2027-06-21 (estimated)
Study Completion 2027-06-21 (estimated)
Updated on ClinicalTrials.gov 2026-09-23